<DOC>
	<DOCNO>NCT01331720</DOCNO>
	<brief_summary>The aim study ass effectiveness 5 mixed protocol ovarian hyperstimulation urinary gonadotrophin achieve clinical pregnancy female undergo assisted reproductive technique ( IVF/ICSI ) ( in-vitro fertilisation/intracytoplasmic sperm injection ) . Study hypothesis : mixed protocol urinary FSH ( follicle-stimulating hormone ) urinary hMG ( human menopausal gonadotropin ) effective monotherapy .</brief_summary>
	<brief_title>Assessment Effectiveness Tolerability Ovarian Hyperstimulation</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<criteria>Body mass index ( BMI ) 18 30 Prolactin within laboratory normal range Couples affect sterility able treat IVF/ICSI ( invitro fertilisation/intracytoplasmic sperm injection ) Patients undergo Menopur® and/or Bravelle® treatment Normal thyroid function Women receive clomifen citrate gonadotrophin within one month prior study start Couples willing participate study sign informed consent form Failure 3 previous cycle assist reproduction IVF/ICSI ( invitro fertilisation/intracytoplasmic sperm injection ) Policystic ovarian syndrome Seminal sample apt IVFICSI ( accord criterion center ) Evidence significant bacterial infection seminogram couple precede 6 month Antecedents severe ovarian hyperstimulation syndrome ( OHSS ) Important systemic disease Pregnancy contraindication pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>